World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Mar 07
Nerve support cells can repair spinal cord injuries
Human astrocyte cells, the major support cells in the central nervous system, have been found to help repair spinal injury, according to a new study.

Scientists at the University Of Colorado School Of Medicine and the University Of Rochester Medical Center have found an effective way to restore locomotors function through repairing a damaged nervous system with a type of astrocyte cell found in the brain and spinal cord.

The research indicated that transplanting stem cells wasn't nearly as effective as creating and modifying a specific type of cell before transplanting them.

The team created two types of human astrocytes and transplanted them into rats.

One type of astrocyte, bone morphogenetic protein (BMP), gave as much as a 70 per cent increase in the protection of neurons in the spinal cord in rats with spinal cord injuries than the other type of astrocyte, ciliary neurotic factor (CNFT).


The study is different from any other research ever conducted in that it showed that even though cells are derived from the exact same group of original cells, they can have completely different effects when it comes to use and treatment.

Chris Proschel, PhD, lead study author and assistant professor of Genetics at the University of Rochester Medical Center says, "We've shown in previous research that the right types of rat astrocytes are beneficial, but this study brings it up to the human level, which is a huge step.

"What's really striking is the robustness of the effect. Scientists have claimed repair of spinal cord injuries in rats before, but the benefits have been variable and rarely as strong as what we've seen with our transplants."

he study is unique, says Stephen Davies, PhD, first author and associate professor in the Department of Neurosurgery at the University of Colorado School of Medicine, because it showed that astrocytes derived from the same human cell precursors have entirely different functions and produced different results for repairing injured spinal cords.

The researchers say transplanting stem cells directly into the spinal cord and hoping that they will be useful, may not be the best approach-- something they found when they tried it on the rats.

Instead, they isolated human glial precursor cells then exposed them to two different signalling molecules, that encouraged the cells to differentiate into BMP (bone morphogenetic protein) or CNTF (ciliary neurotrophic factor).

When scientists transplanted the BMP human astrocytes, they found significant improvement in the injured rats' movement, measured by their ability to cross a ladder-like track. "Clearly, not all human astrocytes are equal when it comes to promoting repair of the central nervous system," Davies said.


The BMP astrocytes provided the most benefits for protecting injured neurons in the spinal cord.

Jeanette Davies, PhD, assistant professor at the University of Colorado School of Medicine and co-lead author of the study explains, "It is estimated that astrocytes make up the vast majority of all cell types in the human brain and spinal cord, and provide multiple different types of support to neurons and other cells of the central nervous system. "These multiple functions are likely to all be contributing to the ability of the right human astrocytes to repair the injured spinal cord."

The study is promising for treating patients with spinal cord injuries.

Jason Huang, MD, associate professor of Neurosurgery at the University of Rochester Medical Center and Chief of Neurosurgery at Highland Hospital notes the significant clinical implications of the findings.

Modifying human astrocytes that are the major support cells in the central nervous system boosted protection of spinal cord neurons 70 per cent compared to using undifferentiated astrocytes, allowing rats with spinal cord injury to regain movement.

The next step say the scientists is to test the effect of transplanted astrocytes derived from human stem cells in more complex models of severe early and late spinal cord injury.

Mar 07
'Clinical trials to be made transparent'
The country is being wrongly projected as a guinea pig for human clinical trials in the medical field but on the contrary, we are behind other countries in this regard, said Surinder Singh, Drugs Controller General of India.

"Around 1 lakh human clinical trials happen all over the world in a year. Among these, 52,000 trials happen in USA alone. Even Canada is home to large number of such trials whereas only 1.2% of these trial take place in India," he informed.

Singh was the chief guest at a national seminar on 'Regulatory Challenges- Global Pharmaceutical Market', organised by the Indian Pharmaceutical Association on Saturday in the city.

Singh said that a website will be launched soon which would make clinical trials a transparent procedure as it would contain all the previous and present information of the trials and the companies involved in it.

Accepting the fact that there were flaws in the system with respect to regulation of drugs, he said the government was working towards strengthening it. "We are short of manpower or infrastructure in regulating or controlling drugs. Hence the efforts are on to strengthen the state and central drugs control departments," he said and added: "300-400 crores have been released for the state drugs departments." He also said that a significant number of drug inspectors and laboratory specialists are being employed in the state and central drug departments along with the constitution of a new task force.

Singh expressed concerns over the presence of spurious drugs which were affecting the nation.

"We have been getting many letters from the Indian embassies abroad on the spurious drugs imports and its quality. This is bringing a bad reputation to the country." He also informed that UID bar codes will be made compulsory for all medicines soon to authenticate their quality. Also, he said, that there was a proposal to start auditing the foreign pharmaceutical companies which import their medicines into the country.

Speaking on the occasion, RP Meena, director general of Drugs and Copyrights, Andhra Pradesh appealed to the pharmaceutical companies to set up their manufacturing units in the backward areas of the state.

"Many pharma companies are moving to the himalayan states like Himachal pradesh, Uttarakhand and Jammu and Kashmir to set up their plants.

But they should concentrate on setting them up in the backward areas of AP too as this would provide employment to about 60% of the local population," he said.

Delivering the key note address, K Anji Reddy, chairman, Reddy's laboratories felt that there should be more focus on the availability and awareness of generic medicines as it would be helpful in providing cost effective treatment for the common man.

Mar 07
With 17,000 cases, cheating on rise in UK varsities
Cheating is widespread at British varsities, including the prestigious Oxford University, with over 17,000 incidents being recorded during the academic year 2009-2010 , a survey has revealed.

The survey of more than 80 universities has found that academic misconduct is soaring at institutions across the UK, with thousands of students caught plagiarising, trying to bribe lecturers and buying essays from the internet.

However, only a handful of students were expelled for their misdemeanours, the survey found.

Greenwich University recorded the largest number of cheating incidents overall, with 916, compared with 540 in 2005-06 ; Sheffield Hallam had the second largest number with 801 last year, more than 500 of which were for plagiarism.

Loughborough University reported 151 incidents last year of which 43 were committed by postgraduates while East London University said that among its 733 cases of cheating last year there were 612 of plagiarism.

Oxford University reported 12 cases of academic misconduct , including plagiarism, last year and in two cases students were expelled, while others were marked down. The university fined one student for taking revision notes into an exam.

The university fined one student 100 pounds for taking revision notes into an examination and imposed other fines for talking in an examination and taking cell telephones into the examination hall, The Sunday Telegraph reported.

Mar 04
HIV vaccine design program launched in India
The Translational Health Sciences and Technology Institute (THSTI), an autonomous institute of the Government's Department of Biotechnology, and the International AIDS Vaccine Initiative (IAVI) has jointly announced an agreement to operate and fund an HIV vaccine design program in India.

The program, which will cost Rs. 50 crore over five years, will include the establishment of a new laboratory in THSTI campus in New Delhi.

The program will primarily focus on one of the greatest scientific challenges of AIDS vaccine design and development: the elicitation of antibodies capable of neutralizing a broad spectrum of circulating HIV variants, a problem that stems in large part from the almost unparalleled mutability of HIV.

"With 7,100 people newly infected with HIV every day, effective tools to prevent infection are indispensable to the fight against HIV and AIDS," said M.K. Bhan, Secretary of the Department of Biotechnology.

Meanwhile, under the banner of the Indian Drug Users Forum (IDUF), patients who have tested positive for HIV gathered here to opposed the Free Trade Agreement (FTA) with European Union that restricts them access to affordable medicines.

Presenting the painful scenario of their lives, IDUF activist Abou Mere said that the government provides drugs free of cost and if drugs are patented and come under FTA, the prices would increase.

"Government is providing drug free of cost, but if this patent takes place then the cost will go up. But what I am trying to highlight over here is Hepatitis C treatment has been patented and out of hundred, more than 90 percent people are affected and we, people who use drugs are not in a position to afford these drugs," said Abou Mere.

"It may be ex-users or current users, we are not in a position to afford these drugs and many people are dying. Therefore, the platform of Indian drug users has come out to against this free trade agreement," he added.

Abou Mere further informed that maximum people, who have tested positive for HIV, are poor, and the government must reconsider the decision to concur to the FTA.

Rajiv Kafle, a member of the Asia Pacific Network of the HIV-Positive People, said that these drugs are the lifelines of the HIV affected persons and if Government yields to the European Union's dictum, it would spell doomsday for the patients.

"We are here asking for our lives. These drugs mean they are our lifelines. And in the past when we didn't not have access to antiretroviral drugs, I have seen a lot of deaths due to HIV. We used to think that only rich people deserve to live and the poor people will deserve to die because of the cost involved in the drugs," Kafle added. (ANI)

Mar 04
How well our brain functions is based on our family's genes
A new study, led by University of Melbourne, has shown that how well our brain functions is largely based on our family's genetic makeup.

The study provides the first evidence of a genetic effect on how 'cost-efficient' our brain network wiring is, shedding light on some of the brain's make up.

Lead author Dr Alex Fornito from the Melbourne Neuropsychiatry Centre at the University of Melbourne said the findings have important implications for understanding why some people are better able to perform certain tasks than others and the genetic basis of mental illnesses and some neurological diseases.

"The brain tries to maximise its bang-for-buck by striking a balance between making more connections to promote efficient communication and minimising the "cost" or amount of wiring required to make these connections. Our findings indicate that this balance, called 'cost-efficiency', has a strong genetic basis."

"Ultimately, this research may help us uncover which specific genes are important in explaining differences in cognitive abilities, risk for mental illness and neurological diseases such as schizophrenia and Alzheimer's disease, leading to new gene-based therapies for these disorders."

"Although genes play a major role in brain function, the environment and other factors contribute to when things go wrong in cases of mental illness and other brain disorders," he said.

The research team, which included scientists at the Universities of Queensland and Cambridge, UK compared the brain scans of 38 identical and 26 non-identical twins from the Australian Twin Registry.

Using new techniques, the researchers were able to construct detailed maps of each person's brain network and measured the cost-efficiency of network connections for the entire brain, as well as for specific brain regions.

"We found that people differed greatly in terms of how cost-efficient the functioning of their brain networks were, and that over half of these differences could be explained by genes," said Fornito.

Across the entire brain, more than half (60%) of the differences between people could be explained by genes. Some of the strongest effects were observed for regions of the prefrontal cortex which play a vital role in planning, strategic thinking, decision-making and memory.

The study has been published in the international publication The Journal of Neuroscience.

Mar 02
New therapy to 'fool cancer cells into killing themselves'
A Wayne State University School of Medicine researcher has developed a personalized therapy that will fool cancer cells into killing themselves.

Developed by Karli Rosner, assistant professor and director of Research in the Department of Dermatology, the treatment uses genetic constructs that contain a genetically modified enzyme to seek out and destroy cancer cells.

The unique concept, patented by the university, was successfully demonstrated on melanoma cells that are resistant to routine treatments such as chemotherapy or radiotherapy.

The success of the therapy in killing melanoma suggests a similar outcome in treating other cancers.

Rosner modified the genetic code for DNase1, a highly potent DNA-degrading enzyme, and altered its genetic composition by deleting a part of the code, mutating another part and adding an artificial piece of code.

Through these changes, the altered DNA program is translated into a modified protein. In contrast to the natural protein, the modified protein will not be eliminated from the cancer cell, will resist deactivation by cell inhibitors and will gain access to the cell's nucleus. he cancer cell, unaware of the destructive potential of the modified code, translates it into a protein that evades the cell's defence mechanisms and enters the nucleus.

Accepting imperfections first step toward better health
In the nucleus, the protein damages DNA by chopping it into fragments without the need for other medications.

Following damage to DNA, the cell's organelles disintegrate and the cancer cell dies.

This mode of cancer cell elimination leaves no residual debris to alert the immune system to kick in, essentially committing 'the perfect crime', said Rosner.

This is important because the many side effects of current anti-cancer treatments are attributed to activation of the immune system.

The fact that this therapy does not require participation of the patient's immune system to kill cancer cells is a big advantage over other newly developed technologies, such as the cancer vaccine.

Patients with the same cancer type vary in their response to identical treatment because the biological characteristics of the same cancer type usually differ between patients.

As a result, the medical field strives to develop treatments that can be adjusted to each patient.

Customized health messages help quit smoking in 4 months

The structure of Rosner's technology contains Lego-like pieces that together form a genetic construct.

Each piece can be replaced by one of several other genetic pieces that perform the same task, but differ slightly in their genetics.

The multiple options available for each genetic piece will allow the physician to tailor the finalized treatment to each patient based on the unique characteristics of his or her cancer.

In this way, the new technology is a 'true personalized therapy', according to Rosner.

Mar 02
Deteriorating Mental Health In Males Predicted
A new research revealed that the number of men with depressive disorder could go up as the century progresses.

Study author Boadie Dunlop of Emory University in the US stated, "Compared to women, many men attach a great importance to their roles as providers and protectors of their families."

"Failure to fulfil the role of breadwinner is associated with greater depression and marital conflict," Dunlop added.

The new study indicated that since the beginning of the downturn in the year 2007, about 75% of the jobs lost in the United States were held by men.

In contrast, women are progressively turning the primary household money makers with 22% of wives making more than their hubbies in 2007, against only 4% during 1970.

Unfortunately, there is small reason for anyone to consider that customary male jobs will return in significant numbers with the recovery in economic system.

In addition, biological as well as sociological differences in males and females may make it more difficult for men to be incorporated in the role of primary care provider to young kids than most females.

Dunlop said, "Men in the changing economy will face the same risks for depression that women faced in older economies: trapped in a family role from which they cannot escape because of an inability to find employment."

Lastly, the societal hope of males to be harsh, stoic and concealing their emotions is being considerably eroded.

Feb 28
New Test for Detecting Lung Cancer in Non-smokers
Scientists from the Mayo Clinic in Rochester, US have now developed a new, cheaper and faster method to detect certain types of lung cancer in patients with no history of smoking.

About 8-12% people who have never smoked a single cigarette suffer from lung adeno carcinoma. A protein called 'anaplastic lymphoma kinase' (ALK) is present in the tumor which grows in such patients. Such a tumor is most likely to be detected among younger people and is more aggressive than the other types of tumors. The disease progression is more than double the progression rate of ALK-negative lung cancer tumor.

Immunohistochemistry (IHC) can be used to detect lung cancer by testing antigens or proteins in the tumor. Study leader, Dr. Ping Yang said, "This discovery could make it easier for doctors to select the best courses of treatment for individual patients. Because it is already performed in most pathology labs, (IHC) testing can be done on-site versus sending a sample to another diagnostic testing site."

Feb 28
Low Vitamin D Linked to Allergy Risk in Kids
The data came from the National Health and Nutrition Examination Survey 2005-2006 (NHANES), which is a program of studies aimed at assessing the health and nutritional status of adults and children in the U.S.

The study participants underwent blood tests measuring levels of Immunoglobulin E(IgE), a protein that is produced when the immune system responds to allergens.

Researchers say their findings don't prove that insufficient vitamin D causes allergies in children and adolescents, but strongly suggests that young people should get adequate amounts of the vitamin.

"The latest dietary recommendations calling for children to take in 600 IU of vitamin D daily should keep them from becoming vitamin D deficient," researcher Michal Melamed, MD, MHS, of the Albert Einstein College Medicine of Yeshiva University, says in a news release.

The study says vitamin D is thought to have anti-inflammatory effects in the body.

The researchers note that the prevalence of vitamin D deficiency is increasing in the U.S., and so is the prevalence of food allergies.

The study is published in the Feb. 17 online edition of the Journal of Allergy and Clinical Immunology.

Feb 26
Running for cancer research
After the marathon, Mumbaikars can gear up for one more race on February 27. But this race will be of a different kind as there will be no winners nor losers.

The Terry Fox Run is a non-competitive event conducted to raise funds for the Tata Memorial Hospital and Cancer research. In a meet held at Trident on Friday, Judith Fox-Alder, sister of Terry Fox, said that the run in India is the second largest in the world. ''Thirty-four countries participate in the Terry Fox Run. It is amazing to see how Terry, who had run the Marathon of Hope 30 year ago, has won the hearts of people all over the world,'' said Judith.

The event will be held on February 27 at 8 am and will begin from Air-India building at Nariman Point to Marine Drive flyover and back to Brabourne Stadium. Around 50-60 schools will participate in the run. State DGP D Sivanandan and singer Raageshwari will flag off the run.have one more reason to run. But this time it will be to raise funds for cancer research.

It is time to run for a cause once again and this time, Mumbaikars will run just for the sheer joy of running. The Terry Fox Run is a non-competitive event where people get together as individuals, families and groups to raise money, proceeds of which will go to the Tata Memorial Hospital for Cancer research.


In an event held at Trident on Friday, Judith Fox-Alder, sister of Terry Fox said she marvelled at how much the annual run had been able to do for cancer research, and how much it continued to do. The Run in India is now the second biggest run in the world! "We have 34 countries that are doing Terry Fox runs now. It's quite amazing that Terry 30 years ago did his Marathon of Hope and captured a nation, and now he has captured the hearts of people all over the world" said Fox-Alder.


The Terry Fox Run will be held on February 27 at 8.00 a.m. from Air-India Building (Nariman Point) to Marine Drive Flyover and back to Brabourne Stadium. 50-60 schools will participate in this run. State director-general of police D Sivanandan and singer Raageshwari will flag off the Run.

Browse Archive